Frazier Healthcare Partners today announced that Jim Brady has been
named an Operating Partner on the firm’s Growth Buyout team.
Mr. Brady brings almost 30 years of experience in healthcare as both an
Operating Partner in private equity as well as an executive operator in
software and technology. Most recently Mr. Brady was Healthcare
Operating Partner at Marlin Equity Partners where he helped create and
build a highly successful portfolio including over 20 acquisitions
across multiple sectors within healthcare.
“We are thrilled that Jim has chosen to join Frazier as the firm looks
to build its presence in healthcare IT. His tenured background in the
healthcare information technology industry, as well as his proven
leadership experience, will greatly enhance our investing efforts in the
sector,” said Frazier General Partner Ben Magnano.
About Mr. Brady:
Before joining Marlin, Mr. Brady had extensive executive experience as
an operator in the healthcare IT and services sectors, including as
founder of a successful entrepreneurial startup venture and executive
roles with a number of public companies. Mr. Brady was the founder and
CEO of Payerpath, a web-based claims management system for healthcare
providers and payers founded in the late 1990s. In 2006, Payerpath was
sold to Misys Healthcare Systems, one of the top five healthcare IT
companies in North America. After the sale of Payerpath, Mr. Brady
served as President of Payerpath, a Misys Company, and served on the
Board of Misys Healthcare Systems as well as on the Operating Board of
its parent company, UK-based Misys plc. Prior to founding Payerpath, Mr.
Brady was Vice President of Sales for NDC Health as well as Senior Vice
President of Health Communication Services. He started his career at ADP.
Mr. Brady holds a B.A. degree in Economics from the University of
About Frazier Healthcare Partners:
Founded in 1991, Frazier Healthcare Partners is a leading provider of
growth and venture capital to healthcare companies. With nearly $4.2
billion in total capital raised, Frazier has invested in more than 170
companies with investments ranging from company creation and venture
capital to buyouts of profitable lower-middle market companies. The
firm’s Growth Buyout team invests in healthcare and pharmaceutical
services, medical products and related sectors. The Life Sciences team
invests in therapeutics and related areas that are addressing unmet
medical needs through innovation. Frazier has offices in Seattle, Wash.,
and Menlo Park, Calif., and invests broadly across the U.S., Canada and
For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180625005182/en/